Possible pathogenetic role of vascular, immunological and genetic factors in certain gastoenterological disorders;Vascularis, immunológiai és genetikai tényezok lehetséges patogenetikai szerepe néhány gasztroenterológiai kórképben

Orvosi Hetilap

Volumn 149, Issue 48, 2008, Pages 2269-2276

  Papp, Mária ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Nagyerdei KRT 98   (Hungary)

Author keywords

Anti microbial antibodies; Anti neutrophil cytoplasmic antibodies (ANCA); Celiac disease; Haptoglobin polymorphism; Inflammatory bowel diseases

Indexed keywords

ANTINUCLEAR ANTIBODY; CASPASE RECRUITMENT DOMAIN PROTEIN 15; HAPTOGLOBIN; OUTER MEMBRANE PROTEIN;

ANTIBODY PRODUCTION; ANTIBODY TITER; CELIAC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SACCHAROMYCES CEREVISIAE;

EID: 58049119968     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28463     Document Type: Review

References (46)

1. Wassell, J.: Haptoglobin: function and polymorphism. Clin. Lab., 2000, 46, 547-552.
2. Bresalier, R. S., Byrd, J. C., Tessler, D. és mtsai: A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology, 2004, 127, 741-748.
3. Smeets, M. B., Pasterkamp, G., Lim, S. K. és mtsai: Nitric oxide synthesis is involved in arterial haptoglobin expression after sustained flow changes. FEBS Lett., 2002, 529, 221-224.
4. Wagner, L., Gessl, A., Parzer, S. B. és mtsai: Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytcs. J. Immunol., 1996, 156, 1989-1996.
5. Theilgaard-Monch, K., Jacobsen, L. C., Nielsen, M. J. és mtsai: Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood, 2006, 108, 353-361.
6. Kristiansen, M., Graversen, J. H., Jacobsen, C. és mtsai: Identification of the haemoglobin scavenger receptor. Nature, 2001, 409, 198-201.
7. Langlois, M., Delanghe, J., Philippe, J. és mtsai: Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur. J. Clin. Chem. Clin. Biochem., 1997, 35, 199-205.
8. Arredouani, M., Matthijs, P., Van Hoeyveld, E. és mtsai: Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology, 2003, 108, 144-151.
9. Langlois, M. R., Delaughe, J. R.: Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem., 1996, 42, 1589-1600.
10. Bossuyt, X.: Serologic markers in inflammatory bowel disease. Clin. Chem., 2006, 52, 171-181.
11. Papp, M., Norman, G. L., Altorjay, I. és mtsai: Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J. Gastroenterol., 2007, 13, 2028-2036.
12. Papp M, Altorjay I., Lakatos P. L.: Szerológai vizsgálatok jelentosége gyulladásos bélbetegségekben. Orv. Hetil., 2007, 148, 887-896.
13. Ferrante, M., Henckaerts, L., Joossens, M. és mtsai: New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut, 2007, 56, 1394-1403.
14. Dubinsky, M. C., Lin, Y. C., Dutridge, D. és mtsai: Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am. J. Gastroenterol., 2006, 101, 360-367.
15. Arnott, I. D., Landers, C. J., Nimmo, E. J. és mtsai: Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol., 2004, 99, 2376-2384.
16. Henckaerts, L., Pierik, M, Joossens, M. és mtsai: Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut, 2007, 56, 1536-1542.
17. Yang, S. E., Min, W. K., Park, H. és mtsai: Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem. Ann. Clin. Biochem., 2000, 37, 205-209.
18. Papp, M., Lakatos, P. L.; Hungarian IBD Study Group; Palatka, K. és mtsai: Haptoglobin polymorphisms are associated with Crohn's disease, disease behaviour and extraintestinal manifestations in Hungarian patients. Dig. Dis. Sci., 2007, 52, 1279-1284.
19. Koch, W., Latz, W., Eichinger, M. és mtsai: Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin. Chem., 2002, 48, 1377-1382.
20. Terjung, B., Worman, H. J., Herzog, V. és mtsai: Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin. Exp. Immunol., 2001, 126, 37-46.
21. Savige, J., Gillis, D., Benson, E. és mtsai: International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am. J. Clin. Pathol., 1999, 111, 507-513.
22. Lakatos, P. L., Lakatos, L., Szalay, F. és mtsai: Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J. Gastroenterol., 2005, 11, 1489-1495.
23. Marsh, M. N.: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology, 1992, 102, 330-354.
24. Hill, I. D., Dirks, M. H., Liptak, G. S. és mtsai: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutt., 2005, 40, 1-19.
25. Lennard-Jones, J. E.: Classification of inflammatory bowel disease. Scand. J. Gastroenterol., 1989, 24 (Suppl. 170.), 2-6.
26. Gasche, C., Scholmerich, J., Brynskov, J. és mtsai: A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna, 1998. Inflamm. Bowel Dis., 2000, 6, 8-15.
27. Papp, M., Foldi, L, Nemes, E. és mtsai: Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. Clin. Chem., 2008, 54, 697-704.
28. Papp M., Lakatos P. L.; Hungarian IBD Study Group; Palatka K. és mtsai: Haptoglobin polimorfizmus vizsgálata gyulladásos bélbetegségekben. Orv. Hetil., 2006, 147, 1745-1750.
29. Papp, M., Altorjay, I., Norman, G. L. és mtsai: Sero-reactivity to microbial components in Crohn's disease is associated with ileal involvement, non-inflammatory disease behaviour and NOD2/ CARD15 genotype, but not with response to medical therapy or risk for surgery. Inflamm. Bowel Dis., 2007, 13, 984-992.
30. Branski, D., Fasano, A., Troncone R.: Latest developments in the pathogenesis and treatment of celiac disease. J. Pediatr., 2006, 149, 295-300.
31. Arredouani, M., Matthijs, P., Van Hoeyveld, E. és mtsai: Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology, 2003, 108, 144-151.
32. Catassi, C., Ratsch, I. M., Fabiani, E. és mtsai: Coeliac disease in the year 2000: exploring the iceberg. Lancet, 1994, 343, 200-203.
33. Melamed-Frank, M., Lache, O., Enav, B. I. és mtsai: Structure-function analysis of the antioxidant properties of haptoglobin. Blood, 2001, 98, 3693-3698.
34. Levy, A. P.: Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene. Acta Diabetol., 2003, 40 (Suppl. 2.), S330-S333.
35. Levy, A. P., Purushothaman, K. R., Levy, N. S. és mtsai: Down-regulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ. Res., 2007, 101, 106-110.
36. Moestrup, S. K., Moller, H. J.: CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med., 2004, 36, 347-354.
37. Levy, A. P., Moreno, P. R.: Intraplaque hemorrhage. Curr. Mol. Med., 2006, 6, 479-488.
38. Salvati, V. M., Mazzarella, G., Gianfrani, C. és mtsai: Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured cochac intestinal mucosa. Gut, 2005, 54, 46-53.
39. Jue, D. M., Shim, B. S., Kang, Y. S.: Inhibition of prostaglandin synthase activity of sheep seminal vesicular gland by human serum haptoglobin. Mol. Cell. Biochem., 1983, 51, 141-147.
40. Saeed, S. A., Ahmad, N., Ahmed, S.: Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding. Biochem. Biophys. Res. Commun., 2007, 353, 915-920.
41. Forcione, D. G., Rosen, M. J., Kisiel, J. B. és mtsai: Anti- Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut, 2004, 53, 1117-1122.
42. Zholudev, A., Zurakowski, D., Young, W. és mtsai: Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am. J. Gastroenterol., 2004, 99, 2235-2241.
43. Mow, W. S., Vasiliauskas, E. A., Lin, Y. C. és mtsai: Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology, 2004, 126, 414-424.
44. Vasiliauskas, E. A., Kam, L. Y., Karp, L. C. és mtsai: Marker anti-body expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut, 1998, 47, 487-496.
45. Abreu, M. T., Taylor, K. D., Lin, Y. C. és mtsai: Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology, 2002, 123, 679-688.
46. Dassopoulos, T., Franyakis, C., Cruz-Correa, M. és mtsai: Anti-bodies to Saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm. Bowel Dis., 2007, 13, 143-151.